Adept icodextrin: Phase III PAMELA data

Preliminary analysis from the double-blind U.S. Phase III PAMELA trial

Read the full 106 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE